Review current Retatrutide research availability, pack options, and batch-specific specifications through the Peptides of China sourcing platform.
Retatrutide is the newest triple-agonist compound moving through china peptide catalogs. As with every fast-rising chinese peptides listing, the first wave of supply attracts opportunistic sellers and diluted batches. Research buyers who order retatrutide through our platform get factory-sourced material with the manufacturer’s own specification — the same discipline we apply across the entire catalog.
Retatrutide Research Peptide | Peptides of China Catalog Retatrutide Retatrutide Research Peptide Retatrutide is a weight management research compound currently in stock directly from a verified Chinese manufacturer. Product specifications are confirmed for the selected manufacturer and batch before the order is finalized. Sourcing is direct — no intermediaries. Public catalog minimum is $300 in goods per supplier. Eligible new customers may use one first-order trial without a monetary minimum; 5% off goods applies from $3,500 per supplier, excluding shipping. International shipping available.
Compound Profile
Retatrutide (LY3437943) is an investigational, once-weekly triple agonist targeting the GIP, GLP-1 and glucagon receptors. Lilly has reported positive Phase 3 topline results from the TRIUMPH program. Retatrutide is not currently approved by the FDA. Published clinical research has evaluated retatrutide in metabolic-disease research, including obesity, type 2 diabetes and related cardiometabolic endpoints. It remains an investigational compound. Product specifications are confirmed for the selected manufacturer and batch before the order is finalized. All supply is for laboratory research use only and is not for human consumption.
Profile
Research Areas
Obesity, metabolic syndrome, type 2 diabetes, MASH/NAFLD, cardiovascular risk markers, thermogenesis
Available Variants
| Name | Strength | Pack Size | Purity | Availability |
|---|---|---|---|---|
| Retatrutide | 5 mg | 10 vials | — | In Stock |
| Retatrutide | 5 mg | 10 vials | ≥98% | In Stock |
| Retatrutide | 10 mg | 10 vials | — | In Stock |
| Retatrutide | 10 mg | 10 vials | ≥98% | In Stock |
| Retatrutide | 15 mg | 10 vials | ≥98% | In Stock |
| Retatrutide | 15 mg | 10 vials | — | In Stock |
| Retatrutide | 20 mg | 10 vials | ≥98% | In Stock |
| Retatrutide | 20 mg | 10 vials | — | In Stock |
| Retatrutide | 30 mg | 10 vials | ≥98% | In Stock |
| Retatrutide | 30 mg | 10 vials | — | In Stock |
| Retatrutide | 40 mg | 10 vials | — | In Stock |
Specification Highlights
Research Areas
Obesity and Weight Reduction Research Phase 2 clinical research data on retatrutide demonstrated dose-dependent bodyweight reductions exceeding those reported for tirzepatide and semaglutide at comparable time points. The addition of glucagon receptor agonism to dual GLP-1/GIP activity is investigated for additive fat oxidation and thermogenesis effects — mechanisms being studied in the context of severe obesity and metabolic disease. Type 2 Diabetes and Glycemic Control As a GLP-1R agonist, retatrutide carries glucose-lowering activity through incretin-mediated insulin secretion and glucagon suppression. Phase 2 published data showed meaningful HbA1c reductions alongside substantial bodyweight effects in participants with type 2 diabetes, establishing it as a subject of interest in multi-factorial metabolic disease research. Fatty Liver and Cardiovascular Research Emerging research interest follows the cardiovascular outcome data from related GLP-1 class compounds and early signals from retatrutide’s Phase 2 data regarding liver fat reduction in MASH/NAFLD models. Cardiovascular risk marker changes observed in Phase 2 are being monitored in the ongoing Phase 3 program as secondary endpoints. ## Sourcing retatrutide From China
retatrutide is available through our platform as a china peptide sourced directly from an established Chinese manufacturer. Three points define how we handle it:
- Factory-direct, not trader-sourced. We confirm availability and specification with the manufacturer before the order is confirmed. There is no intermediary resale of unknown-origin vials in this catalog.
- Specification before shipment. The purity and concentration specification shown on this page is the manufacturer’s batch specification. Product-specific quality-control information travels with the order.
- Research-use discipline. Like every listing in our catalog, retatrutide is supplied for laboratory research use only, under strict research-use terms.
For buyers comparing chinese peptides suppliers, the practical test is whether the seller can name the manufacturer and show the batch documentation. We work the other way around: the manufacturer and the documentation are the offer. Browse the full catalog or see how sourcing works.